Skip to main content

Hyperglycemia

Open Access Hyperglycemia Review

Hyperglycemic crises in adults with diabetes: a consensus report

Update on the epidemiology, pathophysiology, and clinical presentation of DKA and HHS in adults with diabetes, with recommendations for diagnosis, treatment, and prevention.

Editor's Choice

Diabetes technology in the hospital

Diabetes Review

The use of diabetes technology in the inpatient setting is still limited, but integrating smarter glucose monitoring and insulin delivery devices into this environment could reduce diabetes-related morbidity and mortality.

Automated insulin delivery

What you need to know about closed-loop systems for the management of diabetes, from real-world data to expanding indications, access, implementation, and limitations.

Understanding the new EMA guideline on medicinal products for diabetes

Diabetes Therapy Guideline at a Glance

An overview of the revised European Medicines Agency guideline on the clinical investigation of medicinal products for the treatment or prevention of type 1 and 2 diabetes.

Managing exogenous insulin antibody syndrome

Open Access Type 1 Diabetes Case Study

EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Insulins Clinical Trial Summary

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.

Developed by: Springer Medicine

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by: Abbott Diabetes Care

Prof. Samuel Seidu
Developed by: Adis

Case Studies

Managing exogenous insulin antibody syndrome

Open Access Type 1 Diabetes Case Study

EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.

Nonketotic hyperglycemia hemichorea-hemiballismus

Open Access Type 2 Diabetes Case Study

HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.

H syndrome, hyperglycemia, hypogonadism, and growth hormone deficiency

Open Access Hyperglycemia Case Study

H syndrome should be suspected if a patient has short stature, signs of hyperglycemia, and other endocrine and cutaneous abnormalities. Signs include hyperpigmentation, hypogonadism, hyperglycemia, and hallux valgus.

Webinar | 08-11-2023 | 18:00 (CET)

Keynote webinar | Spotlight on diet and diabetes

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

Prof. Mike Lean
Prof. Falko Sniehotta
Developed by: Springer Medicine

Current Reviews

Pregnancy in various forms of monogenic diabetes: A systematic review

Monogenic diabetes (MD) represents a cluster of different types of diabetes produced by a mutation of a single gene. The commonest type of MD is maturity-onset diabetes of the young (MODY) which has several subtypes, and neonatal diabetes mellitus …

Advances in diabetes technology to improve the lives of people with cystic fibrosis

People with cystic fibrosis (CF) are at risk for dysglycaemia caused by progressive beta cell dysfunction and destruction due to pancreatic exocrine disease and fibrosis. CF-related diabetes (CFRD) is a unique form of diabetes that has distinctive …

Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management

Open Access Type 2 Diabetes REVIEW

The prevalence of youth-onset type 2 diabetes (YO-T2D), defined as T2D diagnosed before the age of 25 years, is increasing worldwide [ 1 – 3 ]. In 2021, an estimated 41,600 youth were newly diagnosed with T2D [ 4 ], with incidence varying widely …

Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome

The loss of appetite, anorexia, and weight loss is a common complication in patients with cancer [ 1 ]. Cachexia, defined as the loss of body weight and lean body mass [ 2 ], is associated with fatigue, weakness, decreased physical performance and …

CME & eLearning

Webcast | Videos (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Discussion-based webcast addressing the causes of clinical inertia in type 2 diabetes.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Digital Treatment Map (Link opens in a new window)

Practical, expert-led digital map designed to guide treatment of type 2 diabetes with GLP‑1RAs.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

Further Reading

C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib

Open Access Hyperglycemia Meta-Analysis

Breast cancer is the leading cause of cancer-related death in women worldwide [ 1 , 2 ]. The most common subtype is characterized by hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) tumors [ 3 ].

Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management

Open Access Type 2 Diabetes REVIEW

The prevalence of youth-onset type 2 diabetes (YO-T2D), defined as T2D diagnosed before the age of 25 years, is increasing worldwide [ 1 – 3 ]. In 2021, an estimated 41,600 youth were newly diagnosed with T2D [ 4 ], with incidence varying widely …

Hormone imbalances detected in study participants with pre-diabetes in a Durban-based clinical setting, South Africa

Open Access Insulins Original Article

The African region has the highest proportion (73%) of deaths linked to diabetes in persons aged below 60 years [ 1 , 2 ]. The prevalence of Type II Diabetes Mellitus (T2DM) continues to rise, especially in developing countries [ 2 , 3 ]. This …

Healthy dietary pattern is associated with lower glycemia independently of the genetic risk of type 2 diabetes: a cross-sectional study in Finnish men

Open Access Type 2 Diabetes Original Contribution

Type 2 diabetes (T2D) is increasing globally and is one of the leading causes of morbidity and mortality in the world [ 1 ]. It is preceded by worsening glycemia i.e. prediabetes, which itself is a health hazard [ 2 , 3 ]. Hyperglycemia …